Navigating the transition from research to clinical-scale cell therapy manufacture

Collaboration is essential to bringing cell therapies to market, helping to overcome key hurdles in process development such as cost and scalability, transitioning products from academic research to the clinic, and optimizing cell therapy workflows to maximize efficiency. In this article, we extract learnings from two different ongoing collaborative initiatives, each of which is aimed at addressing cell therapy development challenges.

Please enter your email to access content Read now